Swedbank AB Has $182.40 Million Stock Position in Cigna Group $CI

Swedbank AB raised its holdings in shares of Cigna Group (NYSE:CI) by 7.7% in the 4th quarter, Holdings Channel.com reports. The fund owned 662,728 shares of the health services provider’s stock after buying an additional 47,541 shares during the period. Swedbank AB’s holdings in Cigna Group were worth $182,403,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the business. Brighton Jones LLC grew its position in Cigna Group by 9.3% in the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock valued at $1,032,000 after purchasing an additional 318 shares in the last quarter. Sivia Capital Partners LLC lifted its position in Cigna Group by 10.4% during the 2nd quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider’s stock worth $384,000 after buying an additional 109 shares in the last quarter. NewEdge Advisors LLC boosted its stake in shares of Cigna Group by 4.5% during the 2nd quarter. NewEdge Advisors LLC now owns 22,225 shares of the health services provider’s stock worth $7,347,000 after buying an additional 958 shares during the last quarter. Treasurer of the State of North Carolina grew its holdings in shares of Cigna Group by 16.6% in the 2nd quarter. Treasurer of the State of North Carolina now owns 148,840 shares of the health services provider’s stock valued at $49,204,000 after acquiring an additional 21,173 shares in the last quarter. Finally, Osterweis Capital Management Inc. acquired a new stake in shares of Cigna Group in the second quarter valued at about $163,000. Institutional investors own 86.99% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently commented on CI. TD Cowen increased their price target on Cigna Group from $333.00 to $338.00 and gave the company a “buy” rating in a research report on Monday, February 9th. Leerink Partners upped their price objective on Cigna Group from $270.00 to $297.00 and gave the stock a “market perform” rating in a research note on Friday, February 6th. Robert W. Baird set a $337.00 price objective on Cigna Group in a report on Friday. Truist Financial raised their target price on shares of Cigna Group from $320.00 to $350.00 and gave the company a “buy” rating in a research note on Tuesday, February 17th. Finally, Guggenheim upped their price target on shares of Cigna Group from $334.00 to $338.00 and gave the stock a “buy” rating in a research report on Monday. One investment analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $338.35.

Cigna Group Price Performance

NYSE:CI opened at $275.73 on Wednesday. Cigna Group has a 12-month low of $239.51 and a 12-month high of $338.89. The firm has a market capitalization of $72.94 billion, a price-to-earnings ratio of 11.69, a P/E/G ratio of 0.98 and a beta of 0.30. The stock’s 50 day moving average price is $274.24 and its two-hundred day moving average price is $276.50. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69.

Cigna Group (NYSE:CI) last issued its earnings results on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, topping the consensus estimate of $7.60 by $0.19. The company had revenue of $68.52 billion during the quarter, compared to the consensus estimate of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The firm’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same period in the previous year, the company posted $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, analysts anticipate that Cigna Group will post 30.4 earnings per share for the current year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be issued a $1.56 dividend. This represents a $6.24 annualized dividend and a dividend yield of 2.3%. The ex-dividend date is Thursday, June 4th. Cigna Group’s payout ratio is currently 26.45%.

Insider Activity

In other news, insider Nicole S. Jones sold 2,307 shares of the stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the transaction, the insider directly owned 32,647 shares of the company’s stock, valued at $9,432,044.77. This represents a 6.60% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Everett Neville sold 1,719 shares of the firm’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $496,636.29. Following the sale, the insider owned 5,670 shares of the company’s stock, valued at approximately $1,638,119.70. This represents a 23.26% decrease in their position. The SEC filing for this sale provides additional information. 0.60% of the stock is owned by corporate insiders.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.